Advertisement

Purpose:

The Partin tables represent the most widely used predictor of pathological stage in men with localized prostate cancer (PCa). The accuracy and performance of the tables have been tested across different populations. However, to our knowledge the potential limitations that may stem from differences between transition zone (TZ) and peripheral zone (PZ) prostate cancers has not been explored. We tested the predictive accuracy and performance of the Partin tables according to TZ vs PZ tumor predominance.

Materials and Methods:

Preoperative serum prostate specific antigen, clinical stage and biopsy Gleason sum data on 1,990 patients treated with radical retropubic prostatectomy were used to define the 2001 Partin probabilities of organ confinement and seminal vesicle invasion (SVI). Data on 1,320 patients who underwent staging pelvic lymphadenectomy and radical retropubic prostatectomy were used to define the probabilities of lymph node invasion (LNI) and organ confined disease (OC). ROC area under the curve was used to assess the predictive accuracy of the 2001 Partin tables relative to observed extracapsular extension (ECE), SVI, LNI and OC. Performance characteristics for each prediction were explored graphically with local regression, nonparametric smoothing plots. Results were compared between 222 TZ cancers and 1,768 PZ cancers.

Results:

The 1,990 radical retropubic prostatectomy specimens demonstrated ECE in 689 cases (34.6%) (TZ in 58 or 27.1% and PZ in 631 or 35.8%) and SVI in 224 (TZ in 13 or 6.1% and PZ in 211 or 11.9%). The 1,320 lymphadenectomy specimens demonstrated LNI in 56 cases (TZ in 2 or 0.9% and PZ in 54 or 4.6%). OC was found in 784 cases (59.4%) (TZ in 95 or 69.9% and PZ in 689 or 58.2%). Predictive accuracy was for ECE 76.4% (TZ 69.0% and PZ 77.2%), 78.0% for SVI (TZ 73.5% and PZ 78.3%), 78.6% for LNI (TZ 44.5% and PZ 79.9%) and 79.4% for OC (TZ 73.8% and PZ 80.0%).

Conclusions:

The biological tumor characteristics of TZ PCa differ from those of PZ PCa. These differences appear to undermine the accuracy of pathological stage predictions.

References

  • 1 : Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol1999; 17: 168. Google Scholar
  • 2 : A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst1998; 90: 766. Google Scholar
  • 3 : Biological determinants of cancer progression in men with prostate cancer. JAMA1999; 281: 1395. Google Scholar
  • 4 : Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol1999; 36: 21. Google Scholar
  • 5 : Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer. J Urol1998; 159: 929. LinkGoogle Scholar
  • 6 : Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA1997; 277: 1445. Google Scholar
  • 7 : Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology2001; 58: 843. Google Scholar
  • 8 : Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol2000; 164: 1591. LinkGoogle Scholar
  • 9 : Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol2003; 43: 6. Google Scholar
  • 10 : How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol2003; 167: 1653. Google Scholar
  • 11 : AJCC Cancer Staging Manual. Philadelphia: J. B. Lippincott1992: 181. Google Scholar
  • 12 : Histologic grading and clinical staging of prostate carcinoma. In: Urologic Pathology: The Prostate. Edited by . Philadelphia: Lea and Febiger1977: 171. Google Scholar
  • 13 : Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol1988; 12: 897. Google Scholar
  • 14 : Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone. Prost Cancer Prostatic Dis2002; 5: 279. Google Scholar
  • 15 : Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?. Urology2003; 62: 79. Google Scholar
  • 16 : Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour. Pathology2003; 35: 467. Google Scholar
  • 17 : Molecular genetic aspects of prostate transition zone lesions. Urology2003; 62: 607. Google Scholar
  • 18 : Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores. World J Urol2003; 21: 163. Google Scholar
  • 19 : Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging—initial results. Radiology2003; 229: 241. Google Scholar
  • 20 : Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol2002; 167: 521. LinkGoogle Scholar
  • 21 : Differences in biopsy features between prostate cancers located in the transition and peripheral zone. BJU Int2003; 91: 477. Google Scholar

From the Department of Urology (TS, IL, AH, K-HFC, JW, MG, HH) and Institute of Pathology (AE), University Hospital Hamburg-Eppendorf, Hamburg, Germany, Department of Urology and Health Outcomes Unit, University of Montreal (PIK), Montreal, Quebec, Canada, and Department of Urology, Medical University of Graz (HA), Graz, Austria

Advertisement